Economic impact of dyspepsia in rural and urban Malaysia: A population-based study

Journal of Neurogastroenterology and Motility

Volumn 18, Issue 1, 2012, Pages 43-57

  Mahadeva, Sanjiv ^a   Yadav, Hematram ^b   Everett, Simon M ^c   Goh, Khean Lee ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Asia; Dyspepsia; Health; Population; Quality adjusted life years

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DYSPEPSIA; FEMALE; HEALTH CARE UTILIZATION; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PHARMACEUTICAL CARE; QUALITY OF LIFE; RURAL POPULATION; SOCIAL STATUS; URBAN POPULATION;

EID: 84857621082     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm.2012.18.1.43     Document Type: Article

References (34)

1. Yang SY, Lee OY, Bak YT, et al. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population- based study. Dig Dis Sci 2008;53:188-193.
2. Mahadeva S, Yadav H, Rampal S, Goh KL. Risk factors associated with dyspepsia in a rural Asian population and its impact on quality of life. Am J Gastroenterol 2010;105:904-912.
3. Mahadeva S, Yadav H, Rampal S, Everett SM, Goh KL. Ethnic variation, epidemiological factors and quality of life impairment associated with dyspepsia in urban Malaysia. Aliment Pharmacol Ther 2010;31:1141-1151.
4. Ghoshal UC, Singh R, Chang FY, et al. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil 2011;17:235-244.
5. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003;17:1481-1491.
6. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003;18:387-393.
7. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007;56:321-327.
8. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
9. Haycox A, Einarson T, Eggleston A. The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999;231:38-47.
10. Severens JL, Laheij RJ, Jansen JB, Van der Lisdonk EH, Verbeek AL. Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther 1998;12:919-923.
11. Lu CL, Lang HC, Chang FY, et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol 2005;40:402-411.
12. Department of Statistics Malaysia. Population distribution and basic demographic characteristics. The 2000 Population and Housing Census of Malaysia. Putrajaya: Department of Statistics 2000.
13. Noor Ghani S, Yadav H. Health care in Malaysia. Kuala Lumpur: University of Malaya Press 2008.
14. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982;60:429-462.
15. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford Medical Publications 1997.
16. Moors DS. The basics of statistics. New York: W.H. Freeman & Co. 2000.
17. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. ROME II: the functional gastrointestinal disorders. 2nd ed. Lawrence: Allen Press Inc. 2000.
18. Kwan AC, Bao TN, Chakkaphak S, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003;18: 796-802.
19. MediMedia. Drug Index of Medical Specialities. 2006.
20. Herdman M, Fox-Rushby J, Rabin R, Badia X, Selai C. Producing other language versions of the EQ-5D. In: Brooks R, Rabin R, de Charro F, eds. The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht: Kluwer Academic Publishers 2003:183-190.
21. Mahadeva S, Wee HL, Goh KL, Thumboo J. The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia. BMC Gastroenterol 2009;9:20.
22. Brooks R. EuroQol: the current state of play. Health Policy 1996;37: 53-72.
23. Tolpin HG, Bentkover JD. Economic costs of illness: decision making applications and practical considerations. In: Scheffler R, Rossiter L, eds. Advances in health economic and health service resources. Greenwich (CT): JAI Press 1983:165-197.
24. Henriksson F, Fredrikson S, Masterman T, Jönsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol 2001;8:27-35.
25. Goh KL, Parasakthi N. The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur J Gastroenterol Hepatol 2001;13:177-183.
26. Kang JY, Wee A, Math MV, et al. Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore. Gut 1990;31:850-853.
27. Ariff KM, Teng CL. Rural health care in Malaysia. Aust J Rural Health 2002;10:99-103.
28. Ford AC, Forman D, Bailey AG, Cook MB, Axon AT, Moayyedi P. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study. Am J Gastroenterol 2007;102:957-965.
29. Delaney BC, Qume M, Moayyedi P, et al. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRCCUBE trial). BMJ 2008;336:651-654.
30. Nyrén O, Lindberg G, Lindström E, Marké LA, Seensalu R. Economic costs of functional dyspepsia. Pharmacoeconomics 1992; 1:312-324.
31. Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut 2002;50(suppl 4):iv10-iv12.
32. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol 2010;8:498-503.
33. Wagstaff A, Moreno-Serra R. Europe and central Asia's great post-communist social health insurance experiment: Aggregate impacts on health sector outcomes. J Health Econ 2009;28:322-340.
34. Agréus L. Natural history of dyspepsia. Gut 2002;50(suppl 4):iv2- iv9.